These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 31486433)
1. [Opportunistic fungal infections of ent organs. Part 2]. Bezshapochnyy SB; Zachepylo SV; Polianskaya VP; Bobrova NA; Fedorchenko VI Vestn Otorinolaringol; 2019; 84(3):74-81. PubMed ID: 31486433 [TBL] [Abstract][Full Text] [Related]
2. [Opportunistic mycoses of ENT organs. Part 1]. Bezshapochny SB; Zachepilo SV; Polyanskaya VP; Bobrova NA; Fedorchenko VI Vestn Otorinolaringol; 2018; 83(6):67-71. PubMed ID: 30721191 [TBL] [Abstract][Full Text] [Related]
3. OPPORTUNITIES AND PROSPECTS OF MICROBIOLOGICAL DIAGNOSIS OF ENT ORGANS MYCOSES (REVIEW). Bezshapochnyy S; Podovzhnii O; Polianska V; Zachepylo S; Fedorchenko V Georgian Med News; 2020 Nov; (308):36-43. PubMed ID: 33395638 [TBL] [Abstract][Full Text] [Related]
4. [Microbiological procedures for diagnosing mycoses and for antifungal susceptibility testing]. Gadea I; Cuenca-Estrella M; Martín E; Pemán J; Pontón J; Rodríguez-Tudela JL Enferm Infecc Microbiol Clin; 2007 May; 25(5):336-40. PubMed ID: 17504688 [TBL] [Abstract][Full Text] [Related]
5. Antifungal attributes of immunosuppressive agents: new paradigms in management and elucidating the pathophysiologic basis of opportunistic mycoses in organ transplant recipients. Singh N; Heitman J Transplantation; 2004 Mar; 77(6):795-800. PubMed ID: 15077015 [TBL] [Abstract][Full Text] [Related]
6. Respiratory and systemic mycoses: an overview. Randhawa HS Indian J Chest Dis Allied Sci; 2000; 42(4):207-19. PubMed ID: 15597667 [TBL] [Abstract][Full Text] [Related]
7. Antifungals discovery: an insight into new strategies to combat antifungal resistance. Fuentefria AM; Pippi B; Dalla Lana DF; Donato KK; de Andrade SF Lett Appl Microbiol; 2018 Jan; 66(1):2-13. PubMed ID: 29112282 [TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and management of fungal infections and pneumocystis pneumonitis in pediatric cancer patients]. Groll AH; Ritter J Klin Padiatr; 2005 Nov; 217 Suppl 1():S37-66. PubMed ID: 16288352 [TBL] [Abstract][Full Text] [Related]
9. Management of mycoses in patients with hematologic disease and cancer -- review of the literature. Ruhnke M; Maschmeyer G Eur J Med Res; 2002 May; 7(5):227-35. PubMed ID: 12069913 [TBL] [Abstract][Full Text] [Related]
10. Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices. Singh N Clin Infect Dis; 2001 Nov; 33(10):1692-6. PubMed ID: 11641825 [TBL] [Abstract][Full Text] [Related]
13. [Testing the sensitivity of opportunistic agents of mycoses to antimycotic drugs in vitro]. Otcenásek M; Buchta V Cesk Epidemiol Mikrobiol Imunol; 1993 Mar; 42(1):29-34. PubMed ID: 8485769 [TBL] [Abstract][Full Text] [Related]
15. Emerging and less common fungal pathogens. Fleming RV; Walsh TJ; Anaissie EJ Infect Dis Clin North Am; 2002 Dec; 16(4):915-33, vi-vii. PubMed ID: 12512187 [TBL] [Abstract][Full Text] [Related]
16. Problems in antifungal chemotherapy. Stevens DA Infection; 1987; 15(2):87-92. PubMed ID: 3596813 [TBL] [Abstract][Full Text] [Related]
17. The 1998 Garrod lecture. Current and future antifungal therapy: new targets for antifungal agents. Andriole VT J Antimicrob Chemother; 1999 Aug; 44(2):151-62. PubMed ID: 10473222 [TBL] [Abstract][Full Text] [Related]
18. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
19. Update in the epidemiology, prophylaxis, and treatment of fungal infections in patients with hematologic disorders. Hayes-Lattin B; Maziarz RT Leuk Lymphoma; 2004 Apr; 45(4):669-80. PubMed ID: 15160938 [TBL] [Abstract][Full Text] [Related]
20. Managing fungal and viral infection in the immunocompromised host. Jehn U Recent Results Cancer Res; 1988; 108():61-70. PubMed ID: 3051213 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]